Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy
NCT02408926Phase 4Completed
- Sponsor
- University of Antwerp
- Start
- Apr 2015
- Primary completion
- Aug 2018
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of pertussis filamentous haemagglutinin in pertussis, sponsored by University of Antwerp. Started Apr 2015; status: completed.
02
Drugs
pertussis filamentous haemagglutinin
03
Conditions
pertussis
Beyond the preview
Go deeper on NCT02408926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02408926.